What Is the Clinical Significance of the Findings from the Delayed-Start Trial of Rasagiline in Parkinson’s Disease?

Publisher: Karger

E-ISSN: 1423-0208|35|3|213-213

ISSN: 0251-5350

Source: Neuroepidemiology, Vol.35, Iss.3, 2010-07, pp. : 213-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next